Overview
School of Medicine
I am a Reader based in the School of Medicine involved in Medical Education & supporting the Equality, Diversity & Inclusion (EDI) strategy & activities with actions that focus on undergraduate and postgraduate students, early stage career researchers, key transition points for academic staff, all staff career development, flexible working and managing career breaks, organization and culture and raising awareness of EDI.
Publication
2022
- Bowden, S. J., Ellis, L. B., Kyrgiou, M., Fiander, A. N. and Hibbitts, S. 2022. High prevalence of HPV 51 in an unvaccinated population and implications for HPV vaccines. Vaccines 10(10), article number: 1754. (10.3390/vaccines10101754)
2019
- Newton, Z., Hibbitts, S. and Hart, K. 2019. Facilitating small groups; Standardising learning processes to enable and develop tomorrow's doctors. Presented at: C4ME Educator Development Day, Cardiff University, 2016. pp. -.
2017
- Jones, S. E. F., Hibbitts, S., Hurt, C. N., Bryant, D., Fiander, A. N., Powell, N. and Tristram, A. J. 2017. Human Papillomavirus DNA methylation predicts response to treatment using cidofovir and imiquimod in Vulval Intraepithelial Neoplasia 3. Clinical Cancer Research 23(18), pp. 5460-5468. (10.1158/1078-0432.CCR-17-0040)
2016
- Wilson, D. J., Harris, B. H. L., Hibbitts, S. J. and Riley, S. 2016. Medical students - how much science education is needed?. Medical Science Educator 26(3), pp. 403-406. (10.1007/s40670-016-0246-7)
- Jelen, M. M. et al. 2016. Global genomic diversity of Human papillomavirus 11 based on 433 isolates and 78 complete genome sequences. Journal of Virology 90(11), pp. 5503-5513. (10.1128/JVI.03149-15)
- Hibbitts, S., Powell, N., Newton, Z., Patel, S. and Hart, K. 2016. Student selected project opportunities with C21 MB BCh. Presented at: C4ME Educator Development Day, Cardiff University, 2016. pp. -.
- Hibbitts, S., Newton, Z. and Jones, L. 2016. Promoting the scientist within medical students from year one: a practical research experience.. Presented at: AMEE, Barcelona, 28/08/16. pp. -.
2015
- Bryant, D., Hibbitts, S. J., Almonte, M., Tristram, A. J., Fiander, A. N. and Powell, N. G. 2015. Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women. Journal of Clinical Virology 66, pp. 66-71. (10.1016/j.jcv.2015.03.001)
2014
- Tristram, A. et al. 2014. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncology 15(12), pp. 1361-1368. (10.1016/S1470-2045(14)70456-5)
- Palmer, E. et al. 2014. Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions. International Journal of Cancer 135(10), pp. 2437-2443. (10.1002/ijc.28886)
- Bryant, D. et al. 2014. Increased methylation of Human Papillomavirus type 16 DNA correlates with viral integration in Vulval Intraepithelial Neoplasia. Journal of Clinical Virology 61(3), pp. 393-399. (10.1016/j.jcv.2014.08.006)
- White, P. L. et al. 2014. Evaluation of a commercially developed semiautomated PCR-surface-enhanced Raman scattering assay for diagnosis of invasive fungal disease. Journal of Clinical Microbiology 52(10), pp. 3536-3543. (10.1128/JCM.01135-14)
- Raybould, R., Fiander, A., Wilkinson, G. and Hibbitts, S. 2014. HPV integration detection in CaSki and SiHa using detection of integrated papillomavirus sequences and restriction-site PCR. Journal of Virological Methods 206, pp. 51-54. (10.1016/j.jviromet.2014.05.017)
- Bryant, D. et al. 2014. mRNA sequencing of novel cell lines from human papillomavirus type-16 related vulval intraepithelial neoplasia: Consequences of expression of HPV16 E4 and E5. Journal of Medical Virology 86(9), pp. 1534-1541. (10.1002/jmv.23994)
- Beer, H., Hibbitts, S., Brophy, S., Rahman, M., Waller, J. and Paranjothy, S. 2014. Does the HPV vaccination programme have implications for cervical screening programmes in the UK?. Vaccine 32(16), pp. 1828-1833. (10.1016/j.vaccine.2014.01.087)
- Hibbitts, S., White, P. L., Green, J., McNay, G., Graham, D. and Stevenson, R. 2014. Human papilloma virus genotyping by surface-enhanced Raman scattering. Analytical Methods 6(5), pp. 1288-1290. (10.1039/c4ay00155a)
- Hibbitts, S. et al. 2014. UK population based study to predict impact of HPV vaccination. Journal of Clinical Virology 59(2), pp. 109-114. (10.1016/j.jcv.2013.12.002)
- Bryant, D., Tristram, A., Liloglou, T., Hibbitts, S., Fiander, A. and Powell, N. 2014. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade. Journal of Clinical Virology 59(1), pp. 24-29. (10.1016/j.jcv.2013.10.029)
2013
- Powell, N. G. et al. 2013. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: A cross-sectional observational study in Wales and Scotland (UK). Journal of Clinical Virology 58(3), pp. 571-574. (10.1016/j.jcv.2013.08.020)
- Chan, P. K. et al. 2013. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. International Journal of Cancer 132(11), pp. 2528-2536. (10.1002/ijc.27932)
- Bowyer, H. L., Marlow, L. A., Hibbitts, S. J., Pollock, K. G. and Waller, J. 2013. Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine 31(7), pp. 1051-1056. (10.1016/j.vaccine.2012.12.038)
2012
- Hibbitts, S. J. 2012. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Journal of Family Planning and Reproductive Health Care 38(2), pp. 72. (10.1136/jfprhc-2012-100337)
2011
- Bryant, D. et al. 2011. Human papillomavirus type distribution in vulval intraepithelial neoplasia determined using PapilloCheck DNA Microarray. Journal of Medical Virology 83(8), pp. 1358-1361. (10.1002/jmv.22107)
- Peevor, R. J., Jones, J., Fiander, A. N. and Hibbitts, S. J. 2011. Development of optimal liquid based cytology sample processing methods for HPV testing: Minimising the inadequate test result. Journal of Virological Methods 173(2), pp. 374-377. (10.1016/j.jviromet.2011.01.020)
- Powell, N. G., Hibbitts, S. J., Boyde, A., Newcombe, R. G., Tristram, A. J. and Fiander, A. N. 2011. The risk of cervical cancer associated with specific types of human papillomavirus: a case-control study in a UK population. International Journal of Cancer 128(7), pp. 1676-1682. (10.1002/ijc.25485)
- Chan, P. K. S. et al. 2011. Identification of Human Papillomavirus Type 58 Lineages and the Distribution Worldwide. International Journal of Infectious Diseases 203(11), pp. 1565-1573. (10.1093/infdis/jir157)
- Jones, J. et al. 2011. Human papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection. Journal of Clinical Virology 52(2), pp. 88-92. (10.1016/j.jcv.2011.06.021)
2010
- Jones, J. et al. 2010. Human papillomavirus prevalence in women treated for high-grade cervical intraepithelial neoplasia (CIN) [Abstract]. Acta Cytologica 54(3), pp. 429-429.
- Jones, J. et al. 2010. P1-023 Human papillomavirus prevalence in women treated for high-grade cervical intraepithelial neoplasia (CIN) [Abstract]. Acta Cytologica 54(3), pp. 429.
- Tristram, A. J. et al. 2010. P1-034 Cervical cancer and screening history in Wales [Abstract]. Acta Cytologica 54(3), pp. 433.
- Hibbitts, S. J. et al. 2010. P1-018 Base HPV 2009: characterization of HPV infection in cervical smears from young women attending first cervical screening prior to implementation of HPV vaccination [Abstract]. Acta Cytologica 54(3), pp. 427-428.
- Hibbitts, S. J. 2010. TA-CIN, a vaccine incorporating a recombinant HPV fusion protein (HPV16 L2E6E7) for the potential treatment of HPV16-associated genital diseases. Current Opinion in Molecular Therapeutics 12(5), pp. 598-606.
- White, P. L., Hibbitts, S. J., Perry, M. D. and Barnes, R. A. 2010. Candida. In: Liu, D. ed. Molecular Detection of Foodborne Pathogens. Boca Raton, FL: CRC Press, pp. 549-564.
2009
- Jones, J., Powell, N. G., Tristram, A. J., Fiander, A. N. and Hibbitts, S. J. 2009. Comparison of the PapilloCheck® DNA micro-array human papillomavirus detection assay with hybrid capture II and PCR-enzyme immunoassay using the GP5/6+ primer set. Journal of Clinical Virology 45(2), pp. 100-104. (10.1016/j.jcv.2009.02.013)
- Peevor, R. J., Bowden, S., Jones, J., Fiander, A. N. and Hibbitts, S. J. 2009. Human papillomavirus negative but dyskaryotic cervical cytology: re-analysis of molecular testing. Journal of Clinical Virology 44(4), pp. 322-324. (10.1016/j.jcv.2009.01.015)
- Powell, N. G., Boyde, A. M., Tristram, A. J., Hibbitts, S. J. and Fiander, A. N. 2009. The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers. International Journal of Cancer 125(10), pp. 2425-2427. (10.1002/ijc.24571)
- Saleem, A., Tristram, A. J., Fiander, A. N. and Hibbitts, S. 2009. Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?. Minerva Medica 100(6), pp. 503-523.
2008
- Rai, N., Jenkins, G. J. S., McAdam, E., Hibbitts, S. J., Fiander, A. N. and Powell, N. G. 2008. Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event. Journal of Clinical Virology 43(2), pp. 250-252. (10.1016/j.jcv.2008.07.004)
- Wat, D. et al. 2008. The role of respiratory viruses in cystic fibrosis. Journal of Cystic Fibrosis 7(4), pp. 320-328. (10.1016/j.jcf.2007.12.002)
- Wat, D., Gelder, C., Hibbitts, S. J., Bowler, I., Pierrepoint, M., Evans, R. and Doull, I. 2008. Is there a role for influenza vaccination in cystic fibrosis?. Journal of Cystic Fibrosis 7(1), pp. 85-88. (10.1016/j.jcf.2007.05.002)
- Hibbitts, S. J. et al. 2008. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. British Journal of Cancer 99(11), pp. 1929-1933. (10.1038/sj.bjc.6604748)
2007
- Fiander, A. N., Hart, K. W., Hibbitts, S. J., Rieck, G. C., Tristram, A. J., Beukenholdt, R. W. and Powell, N. G. 2007. Variation in human papillomavirus type-16 viral load within different histological grades of cervical neoplasia. Journal of Medical Virology 79(9), pp. 1366-1369. (10.1002/jmv.20875)
- Hibbitts, S. J. and Gelder, C. 2007. Viruses in COPD. In: Stockley, R. et al. eds. Chronic Obstructive Pulmonary Disease: A Practical Guide to Management. Oxford: Blackwell, pp. 408-418., (10.1002/9780470755976.ch35)
2006
- Hibbits, S. J., Hart, K. W., Rieck, G. C., Powell, N. G., Hauke, A. and Fiander, A. N. 2006. Human papillomavirus infection: an Anonymous Prevalence Study in South Wales, UK. British Journal of Cancer 95(2), pp. 226-32. (10.1038/sj.bjc.6603245)
2005
- White, P. L. and Hibbitts, S. J. 2005. Inverse PCR. In: Fuchs, J. and Podda, M. eds. Encyclopedia of Medical Genomics and Proteomics. New York: Marcel Dekker, pp. 687-692., (10.3109/9780203997352.138)
- White, P. L. and Hibbitts, S. J. 2005. Long distance PCR. In: Fuchs, J. and Podda, M. eds. Encyclopedia of Medical Genomics and Proteomics. New York: Marcel Dekker, pp. 735-739., (10.3109/9780203997352.148)
- White, P. L. and Hibbitts, S. J. 2005. Blotting techniques. In: Fuchs, J. and Podda, M. eds. Encyclopedia of Medical Genomics and Proteomics. New York: Marcel Dekker, pp. 135-139., (10.3109/9780203997352.028)
2004
- White, P. and Hibbitts, S. J. 2004. Candida Spp. In: Fuchs, J. and Podda, M. eds. Encyclopedia of Diagnostic Genomics and Proteomics. New York: Marcel Dekker, pp. 199-205.
Articles
- Bowden, S. J., Ellis, L. B., Kyrgiou, M., Fiander, A. N. and Hibbitts, S. 2022. High prevalence of HPV 51 in an unvaccinated population and implications for HPV vaccines. Vaccines 10(10), article number: 1754. (10.3390/vaccines10101754)
- Jones, S. E. F., Hibbitts, S., Hurt, C. N., Bryant, D., Fiander, A. N., Powell, N. and Tristram, A. J. 2017. Human Papillomavirus DNA methylation predicts response to treatment using cidofovir and imiquimod in Vulval Intraepithelial Neoplasia 3. Clinical Cancer Research 23(18), pp. 5460-5468. (10.1158/1078-0432.CCR-17-0040)
- Wilson, D. J., Harris, B. H. L., Hibbitts, S. J. and Riley, S. 2016. Medical students - how much science education is needed?. Medical Science Educator 26(3), pp. 403-406. (10.1007/s40670-016-0246-7)
- Jelen, M. M. et al. 2016. Global genomic diversity of Human papillomavirus 11 based on 433 isolates and 78 complete genome sequences. Journal of Virology 90(11), pp. 5503-5513. (10.1128/JVI.03149-15)
- Bryant, D., Hibbitts, S. J., Almonte, M., Tristram, A. J., Fiander, A. N. and Powell, N. G. 2015. Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women. Journal of Clinical Virology 66, pp. 66-71. (10.1016/j.jcv.2015.03.001)
- Tristram, A. et al. 2014. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncology 15(12), pp. 1361-1368. (10.1016/S1470-2045(14)70456-5)
- Palmer, E. et al. 2014. Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions. International Journal of Cancer 135(10), pp. 2437-2443. (10.1002/ijc.28886)
- Bryant, D. et al. 2014. Increased methylation of Human Papillomavirus type 16 DNA correlates with viral integration in Vulval Intraepithelial Neoplasia. Journal of Clinical Virology 61(3), pp. 393-399. (10.1016/j.jcv.2014.08.006)
- White, P. L. et al. 2014. Evaluation of a commercially developed semiautomated PCR-surface-enhanced Raman scattering assay for diagnosis of invasive fungal disease. Journal of Clinical Microbiology 52(10), pp. 3536-3543. (10.1128/JCM.01135-14)
- Raybould, R., Fiander, A., Wilkinson, G. and Hibbitts, S. 2014. HPV integration detection in CaSki and SiHa using detection of integrated papillomavirus sequences and restriction-site PCR. Journal of Virological Methods 206, pp. 51-54. (10.1016/j.jviromet.2014.05.017)
- Bryant, D. et al. 2014. mRNA sequencing of novel cell lines from human papillomavirus type-16 related vulval intraepithelial neoplasia: Consequences of expression of HPV16 E4 and E5. Journal of Medical Virology 86(9), pp. 1534-1541. (10.1002/jmv.23994)
- Beer, H., Hibbitts, S., Brophy, S., Rahman, M., Waller, J. and Paranjothy, S. 2014. Does the HPV vaccination programme have implications for cervical screening programmes in the UK?. Vaccine 32(16), pp. 1828-1833. (10.1016/j.vaccine.2014.01.087)
- Hibbitts, S., White, P. L., Green, J., McNay, G., Graham, D. and Stevenson, R. 2014. Human papilloma virus genotyping by surface-enhanced Raman scattering. Analytical Methods 6(5), pp. 1288-1290. (10.1039/c4ay00155a)
- Hibbitts, S. et al. 2014. UK population based study to predict impact of HPV vaccination. Journal of Clinical Virology 59(2), pp. 109-114. (10.1016/j.jcv.2013.12.002)
- Bryant, D., Tristram, A., Liloglou, T., Hibbitts, S., Fiander, A. and Powell, N. 2014. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade. Journal of Clinical Virology 59(1), pp. 24-29. (10.1016/j.jcv.2013.10.029)
- Powell, N. G. et al. 2013. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: A cross-sectional observational study in Wales and Scotland (UK). Journal of Clinical Virology 58(3), pp. 571-574. (10.1016/j.jcv.2013.08.020)
- Chan, P. K. et al. 2013. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. International Journal of Cancer 132(11), pp. 2528-2536. (10.1002/ijc.27932)
- Bowyer, H. L., Marlow, L. A., Hibbitts, S. J., Pollock, K. G. and Waller, J. 2013. Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine 31(7), pp. 1051-1056. (10.1016/j.vaccine.2012.12.038)
- Hibbitts, S. J. 2012. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Journal of Family Planning and Reproductive Health Care 38(2), pp. 72. (10.1136/jfprhc-2012-100337)
- Bryant, D. et al. 2011. Human papillomavirus type distribution in vulval intraepithelial neoplasia determined using PapilloCheck DNA Microarray. Journal of Medical Virology 83(8), pp. 1358-1361. (10.1002/jmv.22107)
- Peevor, R. J., Jones, J., Fiander, A. N. and Hibbitts, S. J. 2011. Development of optimal liquid based cytology sample processing methods for HPV testing: Minimising the inadequate test result. Journal of Virological Methods 173(2), pp. 374-377. (10.1016/j.jviromet.2011.01.020)
- Powell, N. G., Hibbitts, S. J., Boyde, A., Newcombe, R. G., Tristram, A. J. and Fiander, A. N. 2011. The risk of cervical cancer associated with specific types of human papillomavirus: a case-control study in a UK population. International Journal of Cancer 128(7), pp. 1676-1682. (10.1002/ijc.25485)
- Chan, P. K. S. et al. 2011. Identification of Human Papillomavirus Type 58 Lineages and the Distribution Worldwide. International Journal of Infectious Diseases 203(11), pp. 1565-1573. (10.1093/infdis/jir157)
- Jones, J. et al. 2011. Human papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection. Journal of Clinical Virology 52(2), pp. 88-92. (10.1016/j.jcv.2011.06.021)
- Jones, J. et al. 2010. Human papillomavirus prevalence in women treated for high-grade cervical intraepithelial neoplasia (CIN) [Abstract]. Acta Cytologica 54(3), pp. 429-429.
- Jones, J. et al. 2010. P1-023 Human papillomavirus prevalence in women treated for high-grade cervical intraepithelial neoplasia (CIN) [Abstract]. Acta Cytologica 54(3), pp. 429.
- Tristram, A. J. et al. 2010. P1-034 Cervical cancer and screening history in Wales [Abstract]. Acta Cytologica 54(3), pp. 433.
- Hibbitts, S. J. et al. 2010. P1-018 Base HPV 2009: characterization of HPV infection in cervical smears from young women attending first cervical screening prior to implementation of HPV vaccination [Abstract]. Acta Cytologica 54(3), pp. 427-428.
- Hibbitts, S. J. 2010. TA-CIN, a vaccine incorporating a recombinant HPV fusion protein (HPV16 L2E6E7) for the potential treatment of HPV16-associated genital diseases. Current Opinion in Molecular Therapeutics 12(5), pp. 598-606.
- Jones, J., Powell, N. G., Tristram, A. J., Fiander, A. N. and Hibbitts, S. J. 2009. Comparison of the PapilloCheck® DNA micro-array human papillomavirus detection assay with hybrid capture II and PCR-enzyme immunoassay using the GP5/6+ primer set. Journal of Clinical Virology 45(2), pp. 100-104. (10.1016/j.jcv.2009.02.013)
- Peevor, R. J., Bowden, S., Jones, J., Fiander, A. N. and Hibbitts, S. J. 2009. Human papillomavirus negative but dyskaryotic cervical cytology: re-analysis of molecular testing. Journal of Clinical Virology 44(4), pp. 322-324. (10.1016/j.jcv.2009.01.015)
- Powell, N. G., Boyde, A. M., Tristram, A. J., Hibbitts, S. J. and Fiander, A. N. 2009. The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers. International Journal of Cancer 125(10), pp. 2425-2427. (10.1002/ijc.24571)
- Saleem, A., Tristram, A. J., Fiander, A. N. and Hibbitts, S. 2009. Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?. Minerva Medica 100(6), pp. 503-523.
- Rai, N., Jenkins, G. J. S., McAdam, E., Hibbitts, S. J., Fiander, A. N. and Powell, N. G. 2008. Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event. Journal of Clinical Virology 43(2), pp. 250-252. (10.1016/j.jcv.2008.07.004)
- Wat, D. et al. 2008. The role of respiratory viruses in cystic fibrosis. Journal of Cystic Fibrosis 7(4), pp. 320-328. (10.1016/j.jcf.2007.12.002)
- Wat, D., Gelder, C., Hibbitts, S. J., Bowler, I., Pierrepoint, M., Evans, R. and Doull, I. 2008. Is there a role for influenza vaccination in cystic fibrosis?. Journal of Cystic Fibrosis 7(1), pp. 85-88. (10.1016/j.jcf.2007.05.002)
- Hibbitts, S. J. et al. 2008. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. British Journal of Cancer 99(11), pp. 1929-1933. (10.1038/sj.bjc.6604748)
- Fiander, A. N., Hart, K. W., Hibbitts, S. J., Rieck, G. C., Tristram, A. J., Beukenholdt, R. W. and Powell, N. G. 2007. Variation in human papillomavirus type-16 viral load within different histological grades of cervical neoplasia. Journal of Medical Virology 79(9), pp. 1366-1369. (10.1002/jmv.20875)
- Hibbits, S. J., Hart, K. W., Rieck, G. C., Powell, N. G., Hauke, A. and Fiander, A. N. 2006. Human papillomavirus infection: an Anonymous Prevalence Study in South Wales, UK. British Journal of Cancer 95(2), pp. 226-32. (10.1038/sj.bjc.6603245)
Book sections
- White, P. L., Hibbitts, S. J., Perry, M. D. and Barnes, R. A. 2010. Candida. In: Liu, D. ed. Molecular Detection of Foodborne Pathogens. Boca Raton, FL: CRC Press, pp. 549-564.
- Hibbitts, S. J. and Gelder, C. 2007. Viruses in COPD. In: Stockley, R. et al. eds. Chronic Obstructive Pulmonary Disease: A Practical Guide to Management. Oxford: Blackwell, pp. 408-418., (10.1002/9780470755976.ch35)
- White, P. L. and Hibbitts, S. J. 2005. Inverse PCR. In: Fuchs, J. and Podda, M. eds. Encyclopedia of Medical Genomics and Proteomics. New York: Marcel Dekker, pp. 687-692., (10.3109/9780203997352.138)
- White, P. L. and Hibbitts, S. J. 2005. Long distance PCR. In: Fuchs, J. and Podda, M. eds. Encyclopedia of Medical Genomics and Proteomics. New York: Marcel Dekker, pp. 735-739., (10.3109/9780203997352.148)
- White, P. L. and Hibbitts, S. J. 2005. Blotting techniques. In: Fuchs, J. and Podda, M. eds. Encyclopedia of Medical Genomics and Proteomics. New York: Marcel Dekker, pp. 135-139., (10.3109/9780203997352.028)
- White, P. and Hibbitts, S. J. 2004. Candida Spp. In: Fuchs, J. and Podda, M. eds. Encyclopedia of Diagnostic Genomics and Proteomics. New York: Marcel Dekker, pp. 199-205.
Conferences
- Newton, Z., Hibbitts, S. and Hart, K. 2019. Facilitating small groups; Standardising learning processes to enable and develop tomorrow's doctors. Presented at: C4ME Educator Development Day, Cardiff University, 2016. pp. -.
- Hibbitts, S., Powell, N., Newton, Z., Patel, S. and Hart, K. 2016. Student selected project opportunities with C21 MB BCh. Presented at: C4ME Educator Development Day, Cardiff University, 2016. pp. -.
- Hibbitts, S., Newton, Z. and Jones, L. 2016. Promoting the scientist within medical students from year one: a practical research experience.. Presented at: AMEE, Barcelona, 28/08/16. pp. -.
Research
Research Career
My scientific research focused on HPV focused epidemiology studies to inform policy and changes to HPV vaccination and cervical screening programme delivery. I led studies in collaboration with Cervical Screening Wales to review the age women should be first invited for screening. This contributed to provision changing from age 20 to age 25 following the introduction of the HPV vaccine to avoid unnecessary treatment in young women.
I argued in favour of a gender neutral vaccination programme in a debate published in the BMJ in 2009 highlighting the wider societal benefits of herd immunity and cost-effectiveness long-term. I contributed to research into the burden of HPV-related disease in men and following the JCVI recommendation to vaccinate boys, I was invited by the BMJ to write a follow up editorial to my original publication, highlighting the significance of this change to policy.
My research into HPV extended Internationally with global collaborations looking into lineages of different HPV types and associated oncogenic risk worldwide.
Teaching
Case Based Learning (2013-2018)
In 2013, I was part of the first Case Based Learning (CBL) faculty responsible for delivery of small group teaching to first year medical undergraduate students in the new C21 MB BCh curriculum. I extended facilitation to first, second year and graduate entry medical students covering two semesters each academic year up until 2018 when I began the Dean of EDI role in the Vice Chancellor Office.
Student Selected Component (SSCs) Director in MB BCh (2013-2018)
My first objective as the SSC Director was to review the 5-year SSC programme, catering for 1,500 students each academic year in what was the new C21 MB BCh programme. SSCs had not been coordinated longitudinally with delivery previously in Years 1-2 led by BIOSI and Years 3-5 led by MEDIC. Developing an SSC team to support this framework we collectively aligned all five years to enable a natural progression for students to develop their skill sets and facilitate design of their own projects in a field of interest.
Personal Tutor
I have been a Personal Tutor since joining the University in Dec 2000, undertaking all current training and currently have approximately 20 personal tutees.
Biography
I attained a First Class BSc (Hons) degree in Molecular Genetics in Biotechnology at Sussex University with a year in industry at DowElanco. I then completed a PhD on HIV-1 tissue variation & cell tropism at University College of London before moving to Cardiff University for my first early career researcher post in the Department of Medical Microbiology developing real-time molecular assays for the detection of respiratory viruses.
I was appointed as a Lecturer in the Department of Obstetrics & Gynaecology where my research focus changed to HPV infection & cancer looking at epidemiology & impact of the HPV vaccination programme on cervical screening programmes & I was later promoted to Senior Lecturer based on Excellence in Research.
In 2013, I moved to the Centre for Medical Education taking a leadership role in the medical curriculum as Director of the Student Selected Component.
In 2016, I was appointed as the Sub-Dean of EDI in the School of Medicine with four key aims:
- To support, develop & promote EDI in practice.
- To advance gender parity in career development.
- To eliminate all forms of discrimination, harassment & victimisation.
- To develop a sustainable positive working environment and culture based upon dignity, courtesy & respect.
From July 2018 to June 2021, I was appointed as the Dean of EDI for the University in the Vice Chancellor Office.
I led development and delivery of the University’s EDI strategy and activities which included:
- Promoting individual and collective contribution to the advancement of EDI across the University.
- Implementing the vision to become a University that delivers equal pay, fair treatment and opportunity for all and creates an open and inclusive community which encourages diversity.
- Shaping the strategic development and provide academic leadership to the delivery of the University Strategic Equality Plan 2020-2024 (SEP).
- Working with Staff Equality Networks, Student Union and Trade Unions to identify and implement relevant activities.
- Chairing the EDI contacts group with representatives from all Schools across the University.
- Working on the promotion and advancement of EDI in relation to the student experience with the PVC Student Experience and Academic Standards and Students’ Union. Work included a focus on the Black, Asian and Minority Ethnic awarding gap within the University, benchmarking to the sector and developing ten recommendations for change with a Senior Staff Engagement Project: An Active Approach to Race Equality.
- Delivery & monitoring progress against the Athena SWAN University action plan in support of gender equality.
- Supporting EDI within the Research Excellence Framework including training to promote an inclusive research culture, equality impact assessments and chair of the individual circumstances group.
- Representing the interests of the University on internal and external committees/working groups e.g. Collaboration with the EHRC on the recent work into racial harassment in the HE sector with Cardiff recognized as having a promising approach with the Race Equality Supervisory Panel.
- Being a high profile champion facilitating widespread visibility and accessibility of the University's values, vision and specific activities to progress EDI through active engagement directly with staff and students.
Outside work, I qualified as a yoga teacher & have been guiding a number of different classes designed to relax & unwind, promote flexibility & strengthen. Also enjoy lots of walking outdoors with the dogs, particularly mountains & beaches.
Honours and awards
May 2019: Enriching Student Life Awards: Vice Chancellor’s Award for Commitment to Student Experience
Nov 2018: Celebrating Excellence Award: School of Medicine EDI team for excellence in Equality, Diversity and Inclusion
March 2016: Rising Star Award BMA Cymru
Jan 2016: Rising Star Award, School of Medicine, Cardiff University
2015-2016: Outstanding contribution award, College of Biomedical and Life Sciences, Cardiff University
2013-2014: Student Prize for Best Case Based Learning Facilitator, School of Medicine, Cardiff University
Professional memberships
- Member of Diversity in Medicine & Health (DIMAH)
- Member of Advance HE EDI Strategic Advisory Group
- Member of the Medical School's Council EDI Reference Group